Massive Illegal Tobacco Warehouse Found in St. Petersburg

Aug.26.2022
Massive Illegal Tobacco Warehouse Found in St. Petersburg
Police discovered a warehouse with 140,000 counterfeit cigarettes worth an estimated 13.5 million rubles in Saint Petersburg.

On August 24th, according to a report from the main department of the Russian Interior Ministry, police discovered a warehouse containing 140,000 packets of counterfeit cigarettes in the Vyborg district of St. Petersburg. The estimated total cost of the counterfeit goods is 13.5 million rubles.


In February 2022, criminal proceedings were initiated against a 50-year-old resident of Saint Petersburg who was charged with trafficking counterfeit tobacco. During the investigation, the location of the warehouse was discovered. "During further investigation, the police began to establish all links in the chain of criminals involved in trafficking fake cigarettes. As a result, several warehouses were found on the Vyborgskoe highway in Saint Petersburg, where a large amount of illegal tobacco was stored," the report stated.


During the search, the police also detained a 42-year-old woman who had registered as a sole proprietor for a warehouse. The investigation suggests that she had purchased counterfeit cigarettes from the detained defendant.


Earlier, authorities discovered an illegal cigarette production site in a stable located in the southern part of Saint Petersburg.


Statement


This article is compiled from third-party information and is intended for industry communication and learning purposes.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the truthfulness or accuracy of the article's content. The translation of this article is solely for industry exchange and research purposes.


Due to limitations in translation ability, the translated article may not fully convey the intended meaning of the original. Therefore, the original text should be referred to for accuracy.


2FIRSTS maintains complete alignment with the Chinese government regarding any domestic, Hong Kong/Macao/Taiwan-related, or foreign-related statements or positions.


The copyright of compiled information belongs to the original media and authors. If there is any infringement, please contact us for deletion.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International announced that the U.S. FDA has accepted the Abbreviated New Drug Application (ANDA) for its Breo® Ellipta® 100/25 generic drug, submitted by its wholly-owned subsidiary, Transpire Bio. Transpire Bio stated that if approved, it is expected to receive 180 days of market exclusivity. In the United States, Breo® Ellipta® is already approved for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).
Sep.25 by 2FIRSTS.ai
Malaysia's Health Minister: Plans to ban the sale of e-cigarettes by mid-2026, starting with open-cell products
Malaysia's Health Minister: Plans to ban the sale of e-cigarettes by mid-2026, starting with open-cell products
Malaysia plans to ban and phase out all e-cigarette sales nationwide by mid-2026, pending cabinet approval.
Sep.26 by 2FIRSTS.ai
Reuters: FDA relaxes requirements for nicotine pouch pilot program, cancels special research on some products
Reuters: FDA relaxes requirements for nicotine pouch pilot program, cancels special research on some products
US FDA meeting minutes: Under Trump, a new pilot eases nicotine pouch rules—cuts product-specific research (uses generic data), shortens reviews, boosts communication. It’s the FDA’s first clear softer stance on smoking alternatives. The pilot may benefit Philip Morris (Zyn), Altria (On!), BAT (Velo) but sparks debate: FDA says pouches are low-risk (no youth surge), while ex-officials/academics cite missing research (hurts health checks, risks hidden youth use). Firms note costly research remain
Sep.19 by 2FIRSTS.ai
Smoking Among Korean Men in Their 30s Plummets as E-Cigarettes Become the Main Substitute
Smoking Among Korean Men in Their 30s Plummets as E-Cigarettes Become the Main Substitute
KDCA reports cigarette smoking among Korean men in their 30s fell from 48% (2015) to 28.5% (2024). Including e-cigarettes, overall use was 40.1% in 2024—just 4.9 points below 2019—suggesting a shift to alternatives.
Oct.09 by 2FIRSTS.ai
PMI Japan to Launch Limited Edition IQOS ILUMA i "Galaxy Blue", Introduces New TEREA Clear Regular Flavo
PMI Japan to Launch Limited Edition IQOS ILUMA i "Galaxy Blue", Introduces New TEREA Clear Regular Flavo
PMI Japan unveils limited edition IQOS ILUMA i in Galaxy Blue, inspired by the universe, set to launch on October 29.
Oct.14 by 2FIRSTS.ai
Plonq Makes Vaping Great Again: How Innovation Helps the Company Strengthen Its Leadership
Plonq Makes Vaping Great Again: How Innovation Helps the Company Strengthen Its Leadership
Moscow, August 30–31, 2025 — Plonq, key partner of VCS, launched the smart POD Meta Smart and STELS chewing tobacco, reinforcing its 30%+ market share and leadership in Russia’s new nicotine sector.
Sep.16